Table 2. Body mass index level between responders and non-responders according to different clinical response criteria.
Responders | Non-responders | |||||
Median | IQR | Median | IQR | Z | p | |
CDAI, LDA | 21,11 | 18.94-23.72 | 20,78 | 20.03-22.29 | 0,02 | 0,98 |
CDAI remission | 21,10 | 18.84-23.68 | 20,81 | 19.15-22.69 | 0,05 | 0,96 |
DAS28-ESR, LDA | 20,83 | 19.29-23.72 | 20,42 | 18.78-22.29 | 0,78 | 0,43 |
DAS28-ESR remission | 20,83 | 19.29-23.72 | 20,42 | 18.86-22.29 | 0,71 | 0,48 |
EULAR good response | 20,83 | 19.29-23.72 | 20,42 | 18.78-22.29 | 0,78 | 0,43 |
ΔDAS28-ESR ≥1.2 | 20,78 | 19.22-23.70 | 21,11 | 18.37-22.31 | 0,62 | 0,54 |
IQR: Interquartile range; CDAI: Clinical disease activity index; LDA: Low disease activity; DAS28: Disease activity score in 28 joints; ESR: Erythrocyte sedi- mentation rate; EULAR: European League Against Rheumatism. |